세계의 조류(Algae) 오메가 3 주입 시장 예측(-2032년) : 유형, 수액 형식, 공급원, 유통 채널, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Algae Omega-3 Infusions Market is accounted for $43.8 million in 2025 and is expected to reach $82.67 million by 2032 growing at a CAGR of 9.5% during the forecast period. The Algae Omega-3 Infusions Market refers to the industry focused on developing and supplying nutritional products infused with omega-3 fatty acids derived from algae. These plant-based sources provide essential nutrients such as DHA and EPA, commonly used in dietary supplements, functional foods, beverages, and pharmaceuticals. Unlike fish oil, algae-derived omega-3 offers a sustainable and vegan-friendly alternative, appealing to health-conscious consumers. Growing awareness of heart, brain, and overall wellness benefits, along with environmental concerns, drives the increasing demand in this market.

According to recent market surveys in the United Kingdom, there has been a 19% increase in daily supplement consumers compared to previous years, highlighting the growing acceptance of omega-3 supplementation.

Market Dynamics:

Driver:

Growing demand for plant-based and vegan nutrition

Algae Omega-3 infusions are increasingly embraced by health-conscious consumers seeking plant-based alternatives to traditional fish oil. The mild taste and versatility of algae-derived oils make them suitable for a wide range of fortified foods, beverages, and supplements. Wellness influencers, nutritionists, and digital platforms are amplifying awareness of algae Omega-3's benefits, driving adoption among trend-driven buyers. Rising disposable incomes and the shift toward premium, eco-friendly nutrition are further accelerating demand. This convergence of ethical, environmental, and health priorities is fueling robust growth in the plant-based Omega-3 segment.

Restraint:

High production and processing costs

The production of algae Omega-3 infusions involves advanced cultivation, extraction, and purification processes that are more expensive than conventional fish oil production. Specialized bioreactors, controlled environments, and stringent quality standards add to operational costs. In regions with limited infrastructure for algae cultivation, scaling production can be challenging and capital-intensive. Maintaining product stability and potency during processing and storage requires investment in advanced encapsulation and packaging technologies. These cost pressures can limit price competitiveness, especially in mass-market applications. As a result, high production expenses remain a key barrier to broader market penetration.

Opportunity:

Rising demand for fortified beverages and supplements

Algae Omega-3 infusions are gaining traction as functional ingredients in fortified drinks, smoothies, and dietary supplements. Their proven benefits for heart, brain, and eye health resonate strongly with wellness-focused consumers. As people increasingly turn to preventive nutrition and natural health solutions, algae Omega-3 offers a sustainable alternative to synthetic or animal-based sources. The growth of personalized nutrition and health tracking is creating demand for targeted, nutrient-rich formulations. Innovations such as microencapsulated Omega-3 for clear beverages and shelf-stable supplement formats are expanding application possibilities. This momentum is opening new revenue streams across both consumer and commercial nutrition sectors.

Threat:

Competition from fish oil Omega-3 suppliers

The algae Omega-3 market faces strong competition from established fish oil producers with well-developed supply chains and brand recognition. Fish oil remains widely available at lower prices, making it a preferred choice for cost-sensitive consumers. Aggressive marketing by fish oil brands emphasizing potency and purity can overshadow algae-based alternatives. In markets where consumer awareness of plant-based Omega-3 is still emerging, fish oil's dominance poses a significant challenge. Regulatory approvals and health claims for fish oil are also more established, giving it an advantage in certain regions.

Covid-19 Impact

The COVID-19 temporarily disrupted the algae Omega-3 infusions market due to supply chain interruptions and reduced production capacity. Lockdowns and transport restrictions affected algae cultivation facilities and delayed product distribution. However, the pandemic also heightened consumer focus on immunity, cardiovascular health, and overall wellness, boosting interest in Omega-3 supplementation. E-commerce channels gained prominence as buyers shifted toward online purchasing of health-oriented products. As economies reopened, demand rebounded strongly, particularly in urban centers with high health awareness.

The DHA-dominant infusions segment is expected to be the largest during the forecast period

The DHA-dominant infusions segment is expected to account for the largest market share during the forecast period, driven by its critical role in supporting brain, eye, and heart health. Consumers and healthcare professionals increasingly recognize DHA's superior bioavailability and targeted benefits compared to other Omega-3 types. Its suitability for infant nutrition, prenatal supplements, and cognitive health products ensures consistent demand across life stages. Food and beverage manufacturers are incorporating DHA-rich algae oils into fortified products to meet rising wellness expectations. Advances in microencapsulation are improving stability and taste, further boosting adoption.

The functional foods & beverages segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the functional foods & beverages segment is predicted to witness the highest growth rate. Rising consumer interest in convenient, nutrient-dense products is fueling innovation in categories such as plant-based milks, protein shakes, and ready-to-drink wellness beverages. Manufacturers are leveraging algae Omega-3's neutral flavor and vegan credentials to appeal to a wide audience. Digital marketing and influencer-led campaigns are increasing awareness of Omega-3's role in preventive health. Improved formulation technologies are enabling clear, stable, and palatable Omega-3 beverages. As functional nutrition becomes mainstream, this segment is set to be the most dynamic growth driver in the market.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to the region's growing middle class, rising health awareness, and strong demand for fortified foods. Countries like China, Japan, and Australia are leading in both consumption and innovation of plant-based nutrition. Government initiatives promoting sustainable aquaculture and alternative proteins are further supporting market expansion. Urbanization and lifestyle changes are increasing interest in premium, functional products. With its large consumer base and supportive policy environment, Asia Pacific is set to remain the anchor region for market growth.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by strong consumer interest in plant-based nutrition and sustainable sourcing. The region's mature health and wellness market is receptive to innovative functional products, including algae Omega-3 infusions. Retailers and e-commerce platforms are expanding access to premium vegan supplements and fortified foods. Regulatory clarity and third-party certifications are enhancing consumer trust in algae-based products. Marketing campaigns highlighting environmental benefits over fish oil are resonating with eco-conscious buyers. With high purchasing power and a culture of health innovation, North America is emerging as a key growth engine for the industry.

Key players in the market

Some of the key players profiled in the Algae Omega-3 Infusions Market include Koninklijke DSM N.V., TerraVia Holdings Inc., BASF SE, Qualitas Health, Corbion N.V., Veramaris V.O.F., Croda International Plc, ADM, Lonza Group AG, GC Rieber Oils AS, Cellana Inc., AlgaSpring B.V., Algisys LLC, Polaris, and Algaecytes Ltd.

Key Developments:

In August 2025, Chemetall strengthens partnership with Circular Plastics Company to drive evolution in plastics recycling in Vietnam. Chemetall will provide a range of novel technologies tailored for Circular Plastics Company's facilities, which recycle post-consumer PET plastics into food-grade products in Myanmar and Vietnam. They include Gardoclean(R) cleaning agents, Gardobond(R) additives for PET/polyolefin separation and defoaming.

In May 2025, dsm-firmenich Animal Nutrition & Health has announced a strategic partnership with Allix, a global leader in feed formulation software, developed by A-Systems, to measure and manage the environmental footprint of animal feed. The two organisations have agreed to combine dsm-firmenich's Sustell(TM), its industry-leading lifecycle assessment (LCA) platform with Allix's feed formulation software to reduce the environmental footprint of feed.

Types Covered:

• DHA-Dominant Infusions
• EPA-Dominant Infusions
• EPA+DHA Blends
• ALA- Alpha-Linolenic Acid

Infusion Formats Covered:

• Ready-to-Drink Functional Beverages
• Clinical & Medical Nutrition Infusions
• Fortified Oils & Emulsions for Infusion
• Nutraceutical Liquid Shots

Sources Covered:

• Microalgae-Derived Oils
• Seaweed-Derived Extracts

Distribution Channels Covered:

• Online Retail & D2C Platforms
• Pharmacies & Health Stores
• Supermarkets/Hypermarkets
• Specialty Nutrition Outlets

Applications Covered:

• Dietary Supplements
• Functional Foods & Beverages
• Clinical & Infant Nutrition
• Pharmaceutical & Therapeutic Use
• Other Applications

End Users Covered:

• Adults
• Children
• Pregnant & Lactating Women
• Elderly Population

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Algae Omega-3 Infusions Market, By Type

• 5.1 Introduction
• 5.2 DHA-Dominant Infusions
• 5.3 EPA-Dominant Infusions
• 5.4 EPA+DHA Blends
• 5.5 ALA- Alpha-Linolenic Acid

6 Global Algae Omega-3 Infusions Market, By Infusion Format

• 6.1 Introduction
• 6.2 Ready-to-Drink Functional Beverages
• 6.3 Clinical & Medical Nutrition Infusions
• 6.4 Fortified Oils & Emulsions for Infusion
• 6.5 Nutraceutical Liquid Shots

7 Global Algae Omega-3 Infusions Market, By Source

• 7.1 Introduction
• 7.2 Microalgae-Derived Oils
• 7.3 Seaweed-Derived Extracts

8 Global Algae Omega-3 Infusions Market, By Distribution Channel

• 8.1 Introduction
• 8.2 Online Retail & D2C Platforms
• 8.3 Pharmacies & Health Stores
• 8.4 Supermarkets/Hypermarkets
• 8.5 Specialty Nutrition Outlets

9 Global Algae Omega-3 Infusions Market, By Application

• 9.1 Introduction
• 9.2 Dietary Supplements
• 9.3 Functional Foods & Beverages
• 9.4 Clinical & Infant Nutrition
• 9.5 Pharmaceutical & Therapeutic Use
• 9.6 Other Applications

10 Global Algae Omega-3 Infusions Market, By End User

• 10.1 Introduction
• 10.2 Adults
• 10.3 Children
• 10.4 Pregnant & Lactating Women
• 10.5 Elderly Population

11 Global Algae Omega-3 Infusions Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Koninklijke DSM N.V.
• 13.2 TerraVia Holdings Inc.
• 13.3 BASF SE
• 13.4 Qualitas Health
• 13.5 Corbion N.V.
• 13.6 Veramaris V.O.F.
• 13.7 Croda International Plc
• 13.8 ADM
• 13.9 Lonza Group AG
• 13.10 GC Rieber Oils AS
• 13.11 Cellana Inc.
• 13.12 AlgaSpring B.V.
• 13.13 Algisys LLC
• 13.14 Polaris
• 13.15 Algaecytes Ltd.